These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33416213)

  • 1. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.
    Mei S; Ge S; Wang J; Li H; Jing X; Liang K; Zhang X; Xue C; Zhang C; Zhang T
    J Pathol Clin Res; 2021 Mar; 7(2):154-164. PubMed ID: 33416213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
    Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
    J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophage-derived CXCL8 could induce ERα suppression via HOXB13 in endometrial cancer.
    Tong H; Ke JQ; Jiang FZ; Wang XJ; Wang FY; Li YR; Lu W; Wan XP
    Cancer Lett; 2016 Jun; 376(1):127-36. PubMed ID: 27018308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
    Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
    Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forkhead-box A1 suppresses the progression of endometrial cancer via crosstalk with estrogen receptor α.
    Wang J; Bao W; Qiu M; Liao Y; Che Q; Yang T; He X; Qiu H; Wan X
    Oncol Rep; 2014 Mar; 31(3):1225-34. PubMed ID: 24452315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells.
    Li S; Hu R; Wang C; Guo F; Li X; Wang S
    Mol Med Rep; 2014 Jun; 9(6):2393-9. PubMed ID: 24715036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of estrogen receptor α and β in the regulation of proliferation in endometrial carcinoma.
    Hu G; Zhang J; Zhou X; Liu J; Wang Q; Zhang B
    Pathol Res Pract; 2020 Oct; 216(10):153149. PubMed ID: 32853964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rap1GAP inhibits tumor progression in endometrial cancer.
    Tamate M; Tanaka R; Osogami H; Matsuura M; Satohisa S; Iwasaki M; Saito T
    Biochem Biophys Res Commun; 2017 Apr; 485(2):476-483. PubMed ID: 28196746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
    Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
    Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-related receptor-γ regulates estrogen receptor-α responsiveness in uterine endometrial cancer.
    Yamamoto T; Mori T; Sawada M; Kuroboshi H; Tatsumi H; Yoshioka T; Matsushima H; Iwasaku K; Kitawaki J
    Int J Gynecol Cancer; 2012 Nov; 22(9):1509-16. PubMed ID: 23051957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancer.
    Backes FJ; Walker CJ; Goodfellow PJ; Hade EM; Agarwal G; Mutch D; Cohn DE; Suarez AA
    Gynecol Oncol; 2016 May; 141(2):312-317. PubMed ID: 26957478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of tumor suppressor gene CDH13 and SHP1 promoters and their epigenetic regulation by the UHRF1/PRMT5 complex in endometrial carcinoma.
    Sheng Y; Wang H; Liu D; Zhang C; Deng Y; Yang F; Zhang T; Zhang C
    Gynecol Oncol; 2016 Jan; 140(1):145-51. PubMed ID: 26597461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
    Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
    Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.
    Watanabe J; Nishizaki R; Jobo T; Kamata Y; Hata H; Nishimura Y; Fujisawa T; Okayasu I; Kuramoto H
    Int J Gynecol Pathol; 2004 Jul; 23(3):234-40. PubMed ID: 15213599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
    He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
    Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression ratios of estrogen receptor α (ERα) to estrogen receptor β1 (ERβ1) and ERα to ERβ2 identify poor clinical outcome in endometrioid endometrial cancer.
    Zannoni GF; Monterossi G; De Stefano I; Gargini A; Salerno MG; Farulla I; Travaglia D; Vellone VG; Scambia G; Gallo D
    Hum Pathol; 2013 Jun; 44(6):1047-54. PubMed ID: 23266443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin.
    Zhang B; Dong S; Li Z; Lu L; Zhang S; Chen X; Cen X; Wu Y
    J Transl Med; 2015 Nov; 13():349. PubMed ID: 26541651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells.
    Al-Dhaheri M; Wu J; Skliris GP; Li J; Higashimato K; Wang Y; White KP; Lambert P; Zhu Y; Murphy L; Xu W
    Cancer Res; 2011 Mar; 71(6):2118-28. PubMed ID: 21282336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.